These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 2996688

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A longitudinal study of antibrain antibodies in multiple sclerosis.
    Ryberg B.
    J Neurol Sci; 1982 May; 54(2):263-70. PubMed ID: 6284884
    [Abstract] [Full Text] [Related]

  • 3. Intrathecal and extrathecal production of antibrain antibodies in multiple sclerosis.
    Ryberg B.
    J Neurol Sci; 1980 Oct; 48(1):1-8. PubMed ID: 7420122
    [Abstract] [Full Text] [Related]

  • 4. Plasmapheresis in multiple sclerosis: preliminary study.
    Weiner HL, Dawson DM.
    Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
    [Abstract] [Full Text] [Related]

  • 5. Plasmapheresis in multiple sclerosis: preliminary findings.
    Dau PC, Petajan JH, Johnson KP, Panitch HS, Bornstein MB.
    Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
    [Abstract] [Full Text] [Related]

  • 6. Complement-fixing antibrain antibodies in multiple sclerosis. Comparison of their occurrence in cerebrospinal fluid and serum.
    Ryberg B.
    Acta Neurol Scand; 1976 Jul; 54(1):1-12. PubMed ID: 936972
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin characterization by bacterial absorption of antibrain antibodies in multiple sclerosis.
    Ryberg B, Kronvall G.
    Eur Neurol; 1981 Jul; 20(5):374-9. PubMed ID: 7285987
    [Abstract] [Full Text] [Related]

  • 8. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.
    Ryberg B.
    J Neurol Sci; 1978 Oct; 38(3):357-82. PubMed ID: 731263
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
    Nagasaka T, Fujii Y, Ishida A, Handa M, Tanikawa A, Amagai M, Nishikawa T.
    Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Antibodies against encephalitogenic protein and myelin glycoprotein in the cerebrospinal fluid of patients with multiple sclerosis. Effect of encorton treatment on the autoantibody and immune complex levels].
    Waigt A, Górny MK.
    Folia Med Cracov; 1984 Apr; 25(3-4):307-18. PubMed ID: 6085729
    [No Abstract] [Full Text] [Related]

  • 16. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982 Apr; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Different types of antibrain antibodies in multiple sclerosis. Studies employing myelin-deficient mutants of mice.
    Ryberg B, Baumann NA.
    J Neurol Sci; 1983 Mar; 58(3):351-5. PubMed ID: 6842263
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The ontogenetic mouse brain model employed in the characterization of antibrain antibodies in multiple sclerosis.
    Ryberg B.
    J Neuroimmunol; 1983 Feb; 4(1):9-15. PubMed ID: 6185539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.